Pyng Medical Corp

Saving lives by saving time through innovation in resuscitation™

San Francisco Fire EMS Selects F.A.S.T.1™

September 11th, 2006

The City of San Francisco Fire Department Emergency Medical Services system has selected the F.A.S.T.1™ from Pyng Medical Corp. for adult intraosseous intervention. Working with EMS Training Section Chief Philip R. Harvey and EMS Training Captain Jeff Myers, Dr. Richard Clinchy, EMT-P, Pyng’s Director of Business Development, assisted in the initial training classes for San Francisco FD paramedics this week, Sep 3 2006.

Serving an immense geographical area and over 1,000,000 people, San Francisco Fire Department responds to over 95,000 alarms annually of which over 70,000 are emergency medical services alarms. The Department transports about 44,000 patients per year. Of these patients an estimated 600+ are cardiac arrests and, based on the recent changes in advanced cardiac life support and the use of adult intraosseous devices in that setting, these cardiac arrest patients will be the initial primary targets for use of the F.A.S.T.1™. As experience is gained with the F.A.S.T.1™, SFFD EMS leaders hope to expand the use of the F.A.S.T.1™ in other appropriate medical emergencies.

Initial F.A.S.T.1™ units have been ordered and will be deployed on the department’s 67 ambulances and fire trucks. Initial use is anticipated to be as high as 500+ units annually.

The Department will submit patient data after each F.A.S.T.1™ use to the ongoing adult intraosseous registry that is being managed by Dr. Clinchy. This registry is already producing evidence as to the effectiveness of the F.A.S.T.1™.

For further information please contact Pyng Medical Corp. at 1-604-303-7964 or visit our web site.

For More Information

David Christie
Pyng Medical Corp.
(604) 303-7964
www.pyng.com

Safe Harbour Statement; Forward-Looking Statements: This release may contain forward-looking statements based on management's expectations, estimates and projections. All statements that address expectations or projections about the future, including statements about the Company's strategy for growth, product development, market position, expected expenditures and financial results are forward-looking statements. Some of the forward-looking statements may be identified by words like "expects", "anticipates", "plans", "intends", "projects", "indicates", and similar expressions. These statements are not guarantees of future performance and involve a number of risks, uncertainties and assumptions. Many factors, including those discussed more fully elsewhere in this release and in documents which may be filed with the British Columbia Securities Commission, the Alberta Securities Commission, the Ontario Securities Commission, the TSX Venture Exchange, as well as other USA Commissions, could cause results to differ materially from those stated. These factors include, but are not limited to changes in the laws, regulations, policies and economic conditions, including inflation, interest and foreign currency exchange rates, of countries in which the Company does business; competitive pressures; successful integration of structural changes, including restructuring plans, acquisitions, divestitures and alliances; cost of raw material, research and development of new products, including regulatory approval and market acceptance; and seasonality of sales in some products.

The TSX Venture Exchange has not reviewed and does not accept responsibility for the adequacy or accuracy of this release.